Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a skin microbiome-based OTC product for atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Good Molecules, LLC | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: RECRUITING